Evidence map›Paper›PMID 20933417›Full record

ArticleBioorganic & medicinal chemistry letters2010

Syntheses of fluorescent imidazoquinoline conjugates as probes of Toll-like receptor 7.

Nikunj M Shukla, Cole A Mutz, Rehman Ukani, Hemamali J Warshakoon, David S Moore, Sunil A David

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis and Optimization of 1-Substituted Imidazo[4,5-ACS medicinal chemistry letters · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Stimulation of innate immune cells by light-activated TLR7/8 agonists.Journal of the American Chemical Society · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Nikunj M ShuklaDepartment of Medicinal Chemistry, University of Kansas, Lawrence, KS 66047, United States.
Cole A Mutz
Rehman Ukani
Hemamali J Warshakoon
David S Moore
Sunil A David
University of Kansas · US

Funding

NIAID NIH HHS HHSN272200900033C
6 · The paper itself

Abstract

Toll-like receptor (TLR)-7 agonists show prominent immunostimulatory activities. The synthesis of a TLR7-active N(1)-(4-aminomethyl)benzyl substituted imidazoquinoline 5d served as a convenient precursor for the covalent attachment of fluorophores without significant loss of activity. Fluorescence microscopy experiments show that the fluorescent analogues are internalized and distributed in the endosomal compartment. Flow cytometry experiments using whole human blood show differential partitioning into B, T, and natural killer (NK) lymphocytic subsets, which correlate with the degree of activation in these subsets. These fluorescently-labeled imidazoquinolines will likely be useful in examining the trafficking of TLR7 in immunological synapses.

Indexed as

AnimalsCell LineFlow CytometryFluorescent DyesHumansLymphocyte SubsetsMiceMicroscopy, FluorescenceQuinolinesStructure-Activity RelationshipToll-Like Receptor 7Fluorescent DyesQuinolinesToll-Like Receptor 7

Identifiers

PMID20933417
PMCPMC2957514
OpenAlexW2041176311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.